Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research

This page shows the latest Cancer Research news and features for those working in and with pharma, biotech and healthcare.

University of Strathclyde develops pre-clinical screening tool which could increase cancer test numbers by up to 50 times

University of Strathclyde develops pre-clinical screening tool which could increase cancer test numbers by up to 50 times

The research, which received funding from AMS Biotechnology Europe, also found that combining CAR-T cell treatment with chemotherapy enhanced treatment efficacy. ... Also involved in the study were researchers at the University of Glasgow and the Cancer

Latest news

More from news
Approximately 29 fully matching, plus 370 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 40 partially matching documents found.

Latest appointments

  • ICR appoints Kristian Helin as its new chief executive ICR appoints Kristian Helin as its new chief executive

    Helin will join ICR in September from the Memorial Sloan Kettering Cancer Center in the US. ... The Institute of Cancer Research, London has appointed Kristian Helin (pictured above) as its new chief executive, with the ‘world-leading’ cancer

  • McCann Health France strengthens team with two new hires McCann Health France strengthens team with two new hires

    Initially, she worked on the research and development of new drugs in cardiovascular and metabolic diseases before specialising in oncology and onco-haematology. ... Prior to McCann Health France, she served as scientific director at various

  • F-star hires ex-BMS immuno-oncology leader

    pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never ... He is an active member of the American Society of Clinical

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... Association for Cancer Research.

More from appointments
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 38 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....